VolitionRx Limited Operating Leases, Future Minimum Payments, Due in Rolling Year Two
VolitionRx Limited (VNRX) had Operating Leases, Future Minimum Payments, Due in Rolling Year Two of $25.33 thousand as of 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInRollingYearTwo · last filed 2019-11-12
- 2019-09-30: Operating Leases, Future Minimum Payments, Due in Rolling Year Two $25.33K.
- 2019-06-30: Operating Leases, Future Minimum Payments, Due in Rolling Year Two $13.35K.
- 2019-03-31: Operating Leases, Future Minimum Payments, Due in Rolling Year Two $13.71K.
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Rolling Year Two $64.89K.
| Period end | Operating Leases, Future Minimum Payments, Due in Rolling Year Two |
|---|---|
| 2019-09-30 | $25.33K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $13.35K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $13.71K 10-Q · filed 2019-05-08 |
| 2018-12-31 | $64.89K 10-K · filed 2019-03-13 |
| 2018-09-30 | $65.72K 10-Q · filed 2018-11-07 |
| 2018-06-30 | $66.26K 10-Q · filed 2018-08-13 |
| 2018-03-31 | $66.24K 10-Q · filed 2018-05-10 |
| 2017-12-31 | $64.25K 10-K · filed 2018-03-01 |
| 2017-09-30 | $221.24K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $179.56K 10-Q · filed 2017-08-10 |
| 2017-03-31 | $164.76K 10-Q · filed 2017-05-11 |
| 2016-12-31 | $161.05K 10-K · filed 2017-03-10 |
| 2016-09-30 | $8.59K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $8.76K 10-Q · filed 2016-08-11 |
| 2016-03-31 | $9.27K 10-Q · filed 2016-05-13 |
| 2015-12-31 | $9.37K 10-K · filed 2016-03-11 |
| 2015-09-30 | $92.06K 10-Q · filed 2015-11-04 |
| 2015-06-30 | $81.82K 10-Q · filed 2015-08-11 |
| 2015-03-31 | $80.06K 10-Q · filed 2015-05-12 |
| 2014-12-31 | $89.65K 10-K · filed 2015-03-18 |
| 2014-09-30 | $2.46K 10-Q · filed 2014-11-06 |
| 2014-06-30 | $2.65K 10-Q · filed 2014-08-01 |
| 2014-03-31 | $2.67K 10-Q · filed 2014-05-15 |
| 2013-12-31 | $2.59K 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |